Published in Chest on February 01, 1992
Can venous-to-arterial carbon dioxide differences reflect microcirculatory alterations in patients with septic shock? Intensive Care Med (2015) 1.59
Central venous-to-arterial carbon dioxide difference as a prognostic tool in high-risk surgical patients. Crit Care (2015) 1.42
Central venous O₂ saturation and venous-to-arterial CO₂ difference as complementary tools for goal-directed therapy during high-risk surgery. Crit Care (2010) 1.10
Persistently high venous-to-arterial carbon dioxide differences during early resuscitation are associated with poor outcomes in septic shock. Crit Care (2013) 1.09
Treatment of acute metabolic acidosis: a pathophysiologic approach. Nat Rev Nephrol (2012) 0.95
The association between physiologic dead-space fraction and mortality in subjects with ARDS enrolled in a prospective multi-center clinical trial. Respir Care (2013) 0.94
Esophageal capnometry during hemorrhagic shock and after resuscitation in rats. Crit Care (2002) 0.89
A large Venous-Arterial PCO(2) Is Associated with Poor Outcomes in Surgical Patients. Anesthesiol Res Pract (2011) 0.85
Acute hyperventilation increases the central venous-to-arterial PCO2 difference in stable septic shock patients. Ann Intensive Care (2017) 0.81
Prognostic value of venoarterial carbon dioxide gradient in patients with severe sepsis and septic shock. Croat Med J (2010) 0.81
Hemodynamic management of cardiovascular failure by using PCO(2) venous-arterial difference. J Clin Monit Comput (2012) 0.79
Venous-to-arterial CO2 differences and the quest for bedside point-of-care monitoring to assess the microcirculation during shock. Ann Transl Med (2016) 0.78
Monitoring CO2 in shock states. J Clin Monit Comput (2014) 0.77
Use of venous-to-arterial carbon dioxide tension difference to guide resuscitation therapy in septic shock. World J Crit Care Med (2016) 0.76
Hyperlactatemia in patients with non-acetaminophen-related acute liver failure. World J Gastroenterol (2006) 0.75
Perfusion indices revisited. J Intensive Care (2017) 0.75
Central Venous to Arterial CO2 Difference After Cardiac Surgery in Infants and Neonates. Pediatr Crit Care Med (2017) 0.75
Venous-to-arterial carbon dioxide differences and the microcirculation in sepsis. Ann Transl Med (2016) 0.75
Clinical review: New technologies -- venturing out of the intensive care unit. Crit Care (2004) 0.75
Early hemodynamic resuscitation in septic shock: understanding and modifying oxygen delivery. Crit Care (2014) 0.75
Monitoring Microcirculatory Blood Flow during Cardiopulmonary Bypass in Paediatric Cardiac Surgery Patients as a Predictor for Anaerobic Metabolism. J Clin Diagn Res (2017) 0.75
Prognostic Value of Venous to Arterial Carbon Dioxide Difference during Early Resuscitation in Critically Ill Patients with Septic Shock. Indian J Crit Care Med (2017) 0.75
Central venous to arterial pCO2 difference in cardiogenic shock. Wien Klin Wochenschr (2012) 0.75
Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med (2001) 27.70
Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA (2001) 10.03
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med (1997) 4.86
Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score. Intensive Care Med (2000) 4.74
The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working Group on Sepsis related Problems of the ESICM. Intensive Care Med (1999) 3.93
Serial blood lactate levels can predict the development of multiple organ failure following septic shock. Am J Surg (1996) 3.31
Has the mortality of septic shock changed with time. Crit Care Med (1998) 3.29
Erythropoietin response is blunted in critically ill patients. Intensive Care Med (1997) 3.20
Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med (1999) 2.93
Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group. Crit Care Med (1993) 2.84
Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest (1993) 2.79
Modular representations of odorants in the glomerular layer of the rat olfactory bulb and the effects of stimulus concentration. J Comp Neurol (2000) 2.79
Global experience in cervical carotid artery stent placement. Catheter Cardiovasc Interv (2000) 2.77
Sedative and analgesic practice in the intensive care unit: the results of a European survey. Br J Anaesth (2001) 2.75
A profile of European intensive care unit physiotherapists. European Society of Intensive Care Medicine. Intensive Care Med (2000) 2.72
Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study. Crit Care Med (2001) 2.56
Methylene blue administration in septic shock: a clinical trial. Crit Care Med (1995) 2.50
Predictive value of microalbuminuria in medical ICU patients: results of a pilot study. Chest (2001) 2.43
The hepatosplanchnic area is not a common source of lactate in patients with severe sepsis. Crit Care Med (2001) 2.34
An open-label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-L-arginine hydrochloride (546C88), in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group. Crit Care Med (1999) 2.33
Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis (1999) 2.32
Physiotherapy for adult patients with critical illness: recommendations of the European Respiratory Society and European Society of Intensive Care Medicine Task Force on Physiotherapy for Critically Ill Patients. Intensive Care Med (2008) 2.31
Blood lactate levels are superior to oxygen-derived variables in predicting outcome in human septic shock. Chest (1991) 2.25
Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study. Circulation (1991) 2.23
Relation between oxygen consumption and oxygen delivery in patients after cardiac surgery. Anesth Analg (1993) 2.12
Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest (1997) 2.07
Interleukin-10 production during septicaemia. Lancet (1994) 2.05
How to use an article on therapy or prevention: pneumonia prevention using subglottic secretion drainage. Crit Care Med (1997) 2.03
Relationship between oxygen uptake and oxygen delivery in septic patients: effects of prostacyclin versus dobutamine. Crit Care Med (1993) 2.00
Current global status of carotid artery stent placement. Cathet Cardiovasc Diagn (1998) 1.99
Effects of methylene blue on oxygen availability and regional blood flow during endotoxic shock. Crit Care Med (1995) 1.97
Serial lactate determinations during circulatory shock. Crit Care Med (1983) 1.93
European participation in major intensive care journals. Intensive Care Med (1995) 1.93
Rotational atherectomy (stentablation) in a lesion with stent underexpansion due to heavily calcified plaque. Catheter Cardiovasc Interv (2001) 1.86
Strong vasopressor support may be futile in the intensive care unit patient with multiple organ failure. Crit Care Med (2000) 1.84
Molecular characterization of an epidemic clone of panantibiotic-resistant Pseudomonas aeruginosa. J Clin Microbiol (2005) 1.83
Perceptual correlates of neural representations evoked by odorant enantiomers. J Neurosci (2001) 1.81
Effects of vasoactive drugs on gastric intramucosal pH. Crit Care Med (1998) 1.77
Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a reevaluation. Crit Care Med (2000) 1.70
Application of SOFA score to trauma patients. Sequential Organ Failure Assessment. Intensive Care Med (1999) 1.66
Human cytokine responses to cardiac transplantation and coronary artery bypass grafting. J Thorac Cardiovasc Surg (1996) 1.63
The Brussels sedation scale: use of a simple clinical sedation scale can avoid excessive sedation in patients undergoing mechanical ventilation in the intensive care unit. Br J Anaesth (1999) 1.63
Hemodynamic responses to successful weaning from mechanical ventilation after cardiovascular surgery. Intensive Care Med (2000) 1.62
Estimating left ventricular filling pressure during positive end-expiratory pressure in humans. Am Rev Respir Dis (1991) 1.61
Single-unit analysis of postnatal olfactory learning: modified olfactory bulb output response patterns to learned attractive odors. J Neurosci (1987) 1.60
Norepinephrine and learning-induced plasticity in infant rat olfactory system. J Neurosci (1989) 1.60
Effects of propofol on human microcirculation. Br J Anaesth (2008) 1.56
Management of dysphagia in suspected esophageal motor disorders. Dig Dis Sci (1991) 1.56
Uric acid, anion gap and urea concentration in the diagnostic approach to hyponatremia. Clin Nephrol (1994) 1.54
Odor-induced increases in c-fos mRNA expression reveal an anatomical "unit" for odor processing in olfactory bulb. Proc Natl Acad Sci U S A (1993) 1.54
Correlation of serial blood lactate levels to organ failure and mortality after trauma. Am J Emerg Med (1995) 1.53
Do established prognostic factors explain the different mortality rates in ICU septic patients around the world? Minerva Anestesiol (2012) 1.53
Molecular epidemiology of an outbreak of multidrug-resistant Enterobacter aerogenes infections and in vivo emergence of imipenem resistance. J Clin Microbiol (1997) 1.51
Sepsis, severe sepsis or sepsis syndrome: need for clarification. Intensive Care Med (1992) 1.48
Coagulopathy induced by hydroxyethyl starch. Anesth Analg (1997) 1.47
Roundtable Conference on Clinical Trials for the Treatment of Sepsis. Brussels, March 12-14, 1994. Chest (1995) 1.47
Comparison of cellulose diacetate and polysulfone membranes in the outcome of acute renal failure. A prospective randomized study. Nephrol Dial Transplant (2000) 1.46
The role of infection in restenosis and atherosclerosis: focus on cytomegalovirus. Lancet (1996) 1.44
Hypertonic saline solution-hetastarch for fluid resuscitation in experimental septic shock. Anesth Analg (1989) 1.44
Prostaglandin E1 infusion for right ventricular failure after cardiac transplantation. J Thorac Cardiovasc Surg (1992) 1.42
Multidimensional chemotopic responses to n-aliphatic acid odorants in the rat olfactory bulb. J Comp Neurol (1999) 1.42
Doctors' perceptions of the effects of interventions tested in prospective, randomised, controlled, clinical trials: results of a survey of ICU physicians. Intensive Care Med (2001) 1.41
Addition of enoximone to adrenergic agents in the management of severe heart failure. Crit Care Med (1992) 1.40
Atropine administration in experimental electromechanical dissociation. Am J Emerg Med (1992) 1.39
Rotational atherectomy or balloon angioplasty in the treatment of intra-stent restenosis: BARASTER multicenter registry. Catheter Cardiovasc Interv (2000) 1.39
Olfactory experience modulates Bcl-2 expression in the developing olfactory bulb. Neuroreport (1995) 1.39
Thermodilution for measurement of cardiac output during artificial ventilation. Intensive Care Med (1988) 1.39
Bretylium tosylate versus lidocaine in experimental cardiac arrest. Am J Emerg Med (1990) 1.39
Administration of dopexamine, a new adrenergic agent, in cardiorespiratory failure. Chest (1989) 1.38
Spatial coding of odorant features in the glomerular layer of the rat olfactory bulb. J Comp Neurol (1998) 1.38
Cardiac tamponade due to spontaneous rupture of right coronary artery aneurysm. Ann Thorac Surg (1996) 1.37
Early olfactory learning induces an enhanced olfactory bulb response in young rats. Brain Res (1986) 1.36
Sensitive period for neural and behavioral response development to learned odors. Brain Res (1987) 1.34
Enhanced neural response to familiar olfactory cues. Science (1984) 1.28
Effects of nitric oxide in septic shock. Am J Respir Crit Care Med (2000) 1.27
Is outcome from ARDS related to the severity of respiratory failure? Eur Respir J (1997) 1.25
Lactate production by the lungs in acute lung injury. Am J Respir Crit Care Med (1997) 1.25
Olfactory classical conditioning in neonates. Pediatrics (1991) 1.21
Spatial patterns of olfactory bulb single-unit responses to learned olfactory cues in young rats. J Neurophysiol (1988) 1.21
Odorant molecular length: one aspect of the olfactory code. J Comp Neurol (2000) 1.16
Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg (1996) 1.14
A profile of European ICU nursing. Intensive Care Med (1998) 1.13
Norepinephrine-induced plasticity and one-trial olfactory learning in neonatal rats. Brain Res Dev Brain Res (1991) 1.13
Noradrenergic modulation of olfactory bulb excitability in the postnatal rat. Brain Res (1988) 1.10
Leukocyte glycolysis and lactate output in animal sepsis and ex vivo human blood. Metabolism (1999) 1.10
Administration of anti-TNF antibody improves left ventricular function in septic shock patients. Results of a pilot study. Chest (1992) 1.10